Pelvic solitary fibrous tumors: clinical manifestations, surgical management and long-term outcomes
Frontiers in Oncology · 31.07.2026 · 16
DOI: 10.3389/fonc.2026.1782133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 31.07.2026. Verfasst von Xinji Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University Third Hospital, Beijing, China. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pelvic solitary fibrous tumor (SFT) is a rare mesenchymal neoplasm with marked clinical and radiological heterogeneity, posing significant diagnostic challenges. Standardized management strategies remain lacking for special clinical scenarios, including paraneoplastic syndromes, synchronous primary malignancies, and pregnancy-associated incidental diagnosis.
Methods
This single-center retrospective case series included 3 consecutive patients with histologically confirmed pelvic SFT who underwent surgical resection at Peking University Third Hospital between October 2018 and September 2025. Clinical, radiological, surgical, pathological, and long-term follow-up data were systematically collected, and a narrative literature review was conducted to refine clinical management.
Results
The three patients presented with distinct rare phenotypes: a 17.5 cm giant tumor complicated by Doege-Potter syndrome, synchronous low-grade bladder urothelial carcinoma, and an asymptomatic tumor incidentally detected during twin pregnancy. All achieved R0 radical resection via individualized open, robot-assisted, or laparoscopic approaches, with no Clavien-Dindo grade ≥II perioperative complications. All tumors showed characteristic nuclear STAT6 positivity and CD34 expression, with uncommon MDM2/CDK4 and SMA/desmin co-expression. At median 36-month follow-up (3–84 months), no recurrence or metastasis was observed.
Conclusions
Complete R0 resection is the cornerstone of pelvic SFT treatment. Individualized surgery is safe even for complex cases. STAT6 positivity is the diagnostic gold standard. High-risk patients may benefit from adjuvant radiotherapy, and lifelong follow-up is mandatory for late recurrence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Peking University Third Hospital, Beijing, China.
Zitieren
APA
Yang, X., Liu, L., & Hou, X. (2026). Pelvic solitary fibrous tumors: clinical manifestations, surgical management and long-term outcomes. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1782133
Vancouver
Yang X, Liu L, Hou X. Pelvic solitary fibrous tumors: clinical manifestations, surgical management and long-term outcomes. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1782133
BibTeX
@article{Yang2026,
author = {Yang, Xinji and Liu, Lei and Hou, Xiaofei},
title = {Pelvic solitary fibrous tumors: clinical manifestations, surgical management and long-term outcomes},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1782133}
}
EUVIMED